Ambulero Company
Ambulero, Inc is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease. Our cell therapy program uses stromal cells engineered to express a cell adhesion molecule called | this helpful?
Industry:
Gene Therapy
Technology:
Cardiovascular Disorders
Funding Status:
Seed
Headquarters:
Miami
Total Funding:
5.5
Founded Date:
2019